Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleeto in acute ischemic stroke
NCT06759753Phase 2Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aleeto in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Mar 2025; status: recruiting.
02
Drugs
Aleeto
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06759753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06759753.